Got probably the same email from Schwab pointing out the pros and cons of "lending my shares". That was for the cash account. No such offer for the IRA account. It probably bothers Schwab that there are millions of shares in these accounts that they can't make interest off of without permission.
I agree that the shorts are controlling the share price as the people with the warrants are most likely waiting for the share price to bump up for a bit more profit before they exercise their warrants.
Somebody earlier asked if anybody knew of other biomedical companies that were hammered and just about destroyed by the shorts. SRPT is one company that survived the lean years 2012-2018, just barely, and are still plagued by the shorts.
Then, as now, patience and understanding that the company's primary drug actually works and can change people's lives is key to riding this out.
PS Blackjack is boring. If you're going to game a bit in the casino, craps, when taking maximum odds, is a lot more fun, IMHO.